Alkem Share Price
(ALKEM)
Check the latest share price of Alkem, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
as on 04:01PM, 02 May 2025
NSE
Alkem Performance
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
₹5,053Day's Price Range₹5,139.552 Week's Low
52 Week's High
₹4,407.0552-Week Price Range₹6,439.9
| Returns % | |
| 1 Month Return | + 2.1 % |
| 3 Month Return | + 0.55 % |
| 1 Year Return | + 3.51 % |
| Market Stats | |
| Previous Close | ₹5,116.00 |
| Open | ₹5,120.00 |
| Volume | 54.49K |
| Upper Circuit | ₹5,627.50 |
| Lower Circuit | ₹4,604.50 |
| Market Cap | ₹60,691.19Cr |
Alkem Fundamentals & Key Indicators
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹60,691.19 Cr
Return on Equity (ROE)
17.56
PE Ratio (TTM)
28.19
Return on capital employed (ROCE)
17.28
Beta (LTM)
0.58
P/B Ratio
5.6
Dividend Yield
0.81
PEG Ratio
0.58
EPS (TTM)
151.52
Sector
Pharmaceuticals
Technical Analysis
Bullish
View Technical Analysis
How to invest in Alkem
Investing in Alkem is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Alkem or ALKEM on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Alkem or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Alkem with just a few clicks!
Alkem Valuation
Track how the P/E of Alkem has moved over time to understand valuation trends.
Alkem in the last 5 years
Lowest (20.07x)
March 24, 2021
Today (28.19x)
May 2, 2025
Industry (54.34x)
May 2, 2025
Highest (44.21x)
August 9, 2023
Today’s Price to Earnings Ratio: 28.19x
Analysts Recommendation on Alkem
Get updated buy, sell, and hold recommendations by analysts on Alkem.
based on 21 analysts
42.86%
Buy
23.81%
Hold
33.33%
Sell
42.86% of analysts recommend a 'HOLD' rating for Alkem. Average target price of ₹5365.71
Source: S&P Global Market Intelligence
Analysts Forecast on Alkem
Get share price movements and forecasts by analysts on Alkem.
Alkem price forecast by 21 analysts
Upside of5.71%
High
₹6642
Target
₹5365.71
Low
₹4186
Alkem target price ₹5365.71, a slight upside of 5.71% compared to current price of ₹5076. According to 21 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Alkem revenue growth forecast
Expected growth rate Q1, FY2027:23.91%
Forecast
Actual
Including amortisation and stock based compensations
Alkem EPS growth forecast
EPS estimate Q1, FY2027:46.27%
Forecast
Actual
Source: S&P Global Market Intelligence
Alkem Financials
Get the annual and quarterly financial summary of Alkem, including revenue, profit, loss and more.
Alkem Index Inclusions
Alkem Earnings and Dividends
View detailed summary of the earnings and dividend history of Alkem.
Alkem Laboratories Ltd Earnings Results
Alkem Laboratories Ltd’s net profit jumped 5.19% since last year same period to ₹625.82Cr in the Q3 2024-2025. On a quarterly growth basis, Alkem Laboratories Ltd has generated -9.12% fall in its net profits since last 3-months.
Read More about Earnings ResultsAlkem Laboratories Ltd Dividends February,2025
In the quarter ending December 2024, Alkem Laboratories Ltd has declared dividend of ₹37 - translating a dividend yield of 1.52%.
Read More about Dividends
Alkem Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Alkem.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 55.13% | 0.00 | |
| Foreign Institutions | 9.41% | 0.00 | |
| Mutual Funds | 14.97% | 0.00 | |
| Retail Investors | 16.05% | 0.00 | |
| Others | 4.45% | 0.00 |
Alkem vs Peers
Compare market cap, revenue, PE, and other key metrics of Alkem with its industry peers.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹60,691.19 Cr | 18.11% | 0.56 | ₹1,811 Cr | ₹12,667 Cr | |
| HOLD | ₹23,352.19 Cr | 16.43% | 0.55 | ₹362 Cr | ₹2,226 Cr | |
| HOLD | ₹33,463.31 Cr | 106.72% | 0.67 | ₹168 Cr | ₹5,040 Cr | |
| BUY | ₹10,231.81 Cr | 12.15% | 0.64 | ₹119 Cr | ₹547 Cr | |
| BUY | ₹4,750.33 Cr | 16.2% | 0.54 | ₹69 Cr | ₹571 Cr |
Alkem News & Key Events
Latest news and events at one place to help you take investing decisions in Alkem.
Alkem Executive Purchases Record-Breaking Mumbai Apartment - 30 Apr, 2025
Sarvesh Singh, executive director of Alkem Laboratories, purchased a luxurious sea-facing duplex flat in Bandra, Mumbai, for Rs 174 crore, marking a record sale in the area.Alkem Completes Acquisition, Target Price Set by HDFC - 17 Apr, 2025
Alkem Laboratories has completed the acquisition of Bombay Ortho Industries, enhancing its orthopedic capabilities. HDFC Securities has set a target price of Rs 5,700 for the stock.
Insights on Alkem Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, ALKEM stock has moved up by 1.0%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 14.01% to 14.97% in Mar 2025 quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 141.8% return, outperforming this stock by 82.7%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 54.5% return, outperforming this stock by 51.0%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 688.64 Cr → 625.82 Cr (in ₹), with an average decrease of 9.1% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 16.18% to 16.05% in Mar 2025 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 55.66% to 55.13% in Mar 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 10.15% to 9.41% in Mar 2025 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 3.54K Cr → 3.46K Cr (in ₹), with an average decrease of 2.3% per quarter
About Alkem
With its headquarters in Mumbai, India, Alkem Laboratories is engaged in the manufacture of a wide range of pharmaceutical products across multiple therapeutic categories, including cardiovascular, central nervous system, gastro-intestinal, anti-infective, diabetology, and nutrition. The company has a strong presence in the Indian market and exports its products to over 50 countries.
Revenue: ₹3,374.28Cr as on December 2024 (Q4 24)
Net Profit: ₹640.79Cr as on December 2024 (Q4 24)
Listing date: 23 Dec, 2015
Chairperson Name: Basudeo N Singh
| Organisation | Alkem Laboratories Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Indian Mutual Funds that own Alkem
Check out the Mutual Funds with significant holdings in Alkem.
FAQs
What is Alkem Laboratories Ltd price today?
Alkem Laboratories Ltd share price today stands at ₹5076, Open: ₹5120, Previous Close: ₹5116, High: ₹5139.5, Low: ₹5053, 52 Week High: ₹6439.9, 52 Week Low: ₹4407.05.
How to Buy Alkem Laboratories Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Alkem Laboratories Ltd shares
What are today's traded volumes of Alkem Laboratories Ltd?
Today's traded volume of Alkem Laboratories Ltd(ALKEM) is 54.49K.
What is today's market capitalisation of Alkem Laboratories Ltd?
Today's market capitalisation of Alkem Laboratories Ltd(ALKEM) is ₹60,691.19 Cr.
What is the 52 Week High and Low Range of Alkem Laboratories Ltd?
How much percentage Alkem Laboratories Ltd is down from its 52 Week High?
Alkem Laboratories Ltd (ALKEM) share price is ₹5076. It is down -21.18% from its 52 Week High price of ₹6439.9
How much percentage Alkem Laboratories Ltd is up from its 52 Week low?
Alkem Laboratories Ltd (ALKEM) share price is ₹5076. It is up 15.18% from its 52 Week Low price of ₹4407.05